USP47-mediated deubiquitination and stabilization of YAP contributes to the progression of colorectal cancer

Beiqing Pan; Yi Yang; Jian Li; Yu Wang; Chuantao Fang; Fa-Xing Yu; Yanhui Xu

doi:10.1007/s13238-019-00674-w

PDF(1938 KB)

Protein Cell ›› 2020, Vol. 11 ›› Issue (2) : 138-143. DOI: 10.1007/s13238-019-00674-w

LETTER

USP47-mediated deubiquitination and stabilization of YAP contributes to the progression of colorectal cancer

Beiqing Pan¹ ,
Yi Yang¹ ,
Jian Li² ,
Yu Wang² ,
Chuantao Fang² ,
Fa-Xing Yu² ,
Yanhui Xu¹^,³^,⁴^,⁵

Author information +

History +

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾

Beiqing Pan, Yi Yang, Jian Li, Yu Wang, Chuantao Fang, Fa-Xing Yu, Yanhui Xu. USP47-mediated deubiquitination and stabilization of YAP contributes to the progression of colorectal cancer. Protein Cell, 2020, 11(2): 138‒143 https://doi.org/10.1007/s13238-019-00674-w

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	An T, Gong Y, Li X, Kong L, Ma P, Gong L, Zhu H, Yu C, Liu J, Zhou H (2017) USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth. Biochem Pharmacol 131:29–39 CrossRef Google scholar

[2]	Barry ER, Morikawa T, Butler BL, Shrestha K, de la Rosa R, Yan KS, Fuchs CS, Magness ST, Smits R, Ogino S(2013) Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature 493:106–110 CrossRef Google scholar

[3]	Cai J, Zhang N, Zheng Y, de Wilde RF, Maitra A, Pan D (2010) The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev 24:2383–2388 CrossRef Google scholar

[4]

Chauhan D, Tian Z, Nicholson B, Kumar KG, Zhou B, Carrasco R, McDermott JL, Leach CA, Fulcinniti M, Kodrasov MP (2012) A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell 22:345–358

CrossRef Google scholar

[5]	Johnson R, Halder G (2014) The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discov 13:63–79 CrossRef Google scholar

[6]	Pan D (2010) The hippo signaling pathway in development and cancer. Dev Cell 19:491–505 CrossRef Google scholar

[7]	Peschiaroli A, Skaar JR, Pagano M, Melino G (2010) The ubiquitinspecific protease USP47 is a novel beta-TRCP interactor regulating cell survival. Oncogene 29:1384–1393 CrossRef Google scholar

[8]	Piccolo S, Dupont S, Cordenonsi M (2014) The biology of YAP/TAZ: hippo signaling and beyond. Physiol Rev 94:1287–1312 CrossRef Google scholar

[9]	Popovic D, Vucic D, Dikic I (2014) Ubiquitination in disease pathogenesis and treatment. Nat Med 20:1242–1253 CrossRef Google scholar

[10]	Steinhardt AA, Gayyed MF, Klein AP, Dong J, Maitra A, Pan D, Montgomery EA, Anders RA (2008) Expression of Yes-associated protein in common solid tumors. Hum Pathol 39:1582–1589 CrossRef Google scholar

[11]	Wang Y, Yu A, Yu FX (2017) The Hippo pathway in tissue homeostasis and regeneration. Protein Cell 8:349–359 CrossRef Google scholar

[12]	Yao F, Zhou Z, Kim J, Hang Q, Xiao Z, Ton BN, Chang L, Liu N, Zeng L, Wang W(2018) SKP2- and OTUD1-regulated nonb proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity. Nat Commun 9:2269 CrossRef Google scholar

[13]	Yu FX, Meng Z, Plouffe SW, Guan KL (2015) Hippo pathway regulation of gastrointestinal tissues. Annu Rev Physiol 77:201–227 CrossRef Google scholar

[14]	Zhang Z, Du J, Wang S, Shao L, Jin K, Li F, Wei B, Ding W, Fu P, van Dam H (2019) OTUB2 promotes cancer metastasis via Hippo-independent activation of YAP and TAZ. Mol Cell 73:7–21.e27 CrossRef Google scholar

[15]	Zhao B, Li L, Tumaneng K, Wang CY, Guan KL (2010) A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev 24:72–85 CrossRef Google scholar